Protein C Inhibitor [clinicaltrials_resource:aa0462beff41049e44a2dab6b7cf2caa]
Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals [clinicaltrials:NCT00001462]Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency [clinicaltrials:NCT00157092]Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency [clinicaltrials:NCT00161707]clinicaltrials:NCT00263887clinicaltrials:NCT00295061clinicaltrials:NCT00301366Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients [clinicaltrials:NCT00499837]clinicaltrials:NCT00500123The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency [clinicaltrials:NCT00532805]clinicaltrials:NCT01054339clinicaltrials:NCT01183455clinicaltrials:NCT01183468clinicaltrials:NCT01213043International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema [clinicaltrials:NCT01217671]Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus [clinicaltrials:NCT01304537]clinicaltrials:NCT01319331Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency [clinicaltrials:NCT01357460]clinicaltrials:NCT01379469Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients [clinicaltrials:NCT01380626]Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients [clinicaltrials:NCT01394835]Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT01419158]Alpha 1 Anti-Trypsin in Treating Patients With Acute Graft-Versus-Host Disease [clinicaltrials:NCT01523821]Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes [clinicaltrials:NCT01661192]clinicaltrials:NCT01669421Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home [clinicaltrials:NCT01676688]A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease [clinicaltrials:NCT01700036]Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort [clinicaltrials:NCT01862211]clinicaltrials:NCT01936896Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) [clinicaltrials:NCT01983241]Phase II-III Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes [clinicaltrials:NCT02005848]clinicaltrials:NCT02014415clinicaltrials:NCT02087813Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus [clinicaltrials:NCT02093221]clinicaltrials:NCT02168686Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery [clinicaltrials:NCT02191839]Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency [clinicaltrials:NCT02273349]clinicaltrials:NCT02363946A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease [clinicaltrials:NCT02503683]clinicaltrials:NCT02520076
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Protein C Inhibitor [clinicaltrials_resource:aa0462beff41049e44a2dab6b7cf2caa]
Bio2RDF identifier
aa0462beff41049e44a2dab6b7cf2caa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:aa0462beff41049e44a2dab6b7cf2caa
identifier
clinicaltrials_resource:aa0462beff41049e44a2dab6b7cf2caa
title
Protein C Inhibitor
@en
type
label
Protein C Inhibitor [clinicaltrials_resource:aa0462beff41049e44a2dab6b7cf2caa]
@en